 Connection
Angela Bryan to Cannabidiol
This is a "connection" page, showing publications Angela Bryan has written about Cannabidiol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.470 |
|
|
|
-
Bryan AD, Skrzynski CJ, Giordano G, Yang J, Stanger M, Bidwell LC, Hutchison KE, Perreault L. Cannabis Use is Associated with Less Peripheral Inflammation but Similar Insulin Sensitivity as Nonuse in Healthy Adults. Am J Med. 2025 Sep; 138(9):1285-1295.
Score: 0.757
-
Bidwell LC, Martin-Willett R, Melendez SN, Rosa L, Giordano G, Hutchison KE, Bryan AD. LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PLoS One. 2024; 19(9):e0308262.
Score: 0.727
-
Bidwell LC, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G, Hutchison KE, Bryan AD. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study. Cannabis Cannabinoid Res. 2024 08; 9(4):1015-1027.
Score: 0.693
-
Gibson LP, Giordano GR, Bidwell LC, Hutchison KE, Bryan AD. Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study. Sports Med. 2024 04; 54(4):1051-1066.
Score: 0.689
-
Delaney RK, Watt MH, Stanger M, Hong I, Bakshi NK, Fagerlin A, Bryan A. Edible Cannabis and Pain, Sleep, and Mental Health Management in Older Adults. JAMA Netw Open. 2026 May 01; 9(5):e2611718.
Score: 0.203
-
Rosa L, Lisano JK, Skrzynski CJ, Bryan AD, Bidwell LC. Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products. Int J Environ Res Public Health. 2026 Feb 10; 23(2).
Score: 0.200
-
Martin-Willett R, Skrzynski CJ, Bryan AD, Bidwell LC. Effects of Cannabinoids on Emotional States and Alcohol Use Among Underrepresented Groups: Moderation by Perceived Discrimination. Hum Psychopharmacol. 2025 09; 40(5):e70016.
Score: 0.194
-
Morris AWJ, Mueller RL, Sempio C, Klawitter J, Bryan AD, Bidwell LC, Hutchison KE. Effect of Cannabidiol and ?9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans. Cannabis Cannabinoid Res. 2025 08; 10(4):506-511.
Score: 0.191
-
Skrzynski CJ, Rosa L, Drake A, Bryan AD, Bidwell LC. Experimental study on cannabis use and affect: Effects on reactivity to and recovery from negative stimuli. J Psychopathol Clin Sci. 2025 Aug; 134(6):639-650.
Score: 0.191
-
Chen MY, Kramer EB, Gibson LP, Bidwell LC, Hutchison KE, Bryan AD. Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use. Cannabis Cannabinoid Res. 2025 02; 10(1):71-80.
Score: 0.176
-
Gibson LP, Mueller RL, Winiger EA, Klawitter J, Sempio C, Williams S, Bryan AD, Bidwell LC, Hutchison KE. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products. Cannabis Cannabinoid Res. 2024 02; 9(1):320-334.
Score: 0.160
-
Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, Bryan AD, Bidwell LC, Hutchison KE. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022 01; 27(1):e13092.
Score: 0.147
-
Gibson LP, Gust CJ, Ellingson JM, YorkWilliams SL, Sempio C, Klawitter J, Bryan AD, Hutchison KE, Cinnamon Bidwell L. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use. Drug Alcohol Depend. 2021 06 01; 223:108718.
Score: 0.143
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|